Moving to remote reviews: a best practice guide for organisations
Subscribe to our mailing list to be notified about new updates
Summary: Interface Clinical Services has provided a GSK funded Patient Review Service in COPD, which since July 2018 has reviewed more than 30,000 patients with unmet need. The Patient Review Service is delivered as a non-promotional medical service provided by a team of clinical pharmacists and provides full clinical reviews of COPD patients and is designed to assist practices in implementing a systematic approach to the management of patients with COPD to reduce symptoms and the risk of exacerbations. Due to the pandemic they transitioned to a remote review model and share their learns about transitioning large organisations.
Posted 25/08/2020 by Scott Sutton
Thank you for your interest in this article. You need to register in order to be able to continue reading. Thank you for your interest in this article. You need to register in order to be able to continue reading.Thank you for your interest in this article. You need to register in order to be able to continue reading.Thank you for your interest in this article. You need to register in order to be able to continue reading.
Thank you for your interest in this article. You need to register in order to be able to continue reading. Thank you for your interest in this article. You need to register in order to be able to continue reading.Thank you for your interest in this article.
Thank you for your interest in this article. You need to register in order to be able to continue reading. Thank you for your interest in this article. You need to register in order to be able to continue reading.Thank you for your interest in this article.
Thank you for your interest in this article. You need to register in order to be able to continue reading. Thank you for your interest in this article. You need to register in order to be able to continue reading.Thank you for your interest in this article.
Register or log in to read this article
In order to continue reading you will need to sign-up to Value.GSK
Register
Already have an account?
Log in
